The FDA approval for aducanumab left clinicians with little guidance on how to select the right patients and ensure their safety. At this year’s Alzheimer's Association International Conference, ...
DENVER, JULY 29 — Research presented at the Alzheimer’s Association International Conference ® (AAIC ®) 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback